Patents Assigned to Morinaga Milk Industry Co., Ltd.
  • Publication number: 20200338140
    Abstract: Provided is a composition for preventing or improving impaired renal function, containing Bifidobacterium breve as an active ingredient. The composition for preventing or improving impaired renal function is capable of reducing blood creatinine levels. The composition for preventing or improving impaired renal function can also be used in a pharmaceutical composition or a food or beverage product composition.
    Type: Application
    Filed: April 25, 2019
    Publication date: October 29, 2020
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Mai Murata, Junichi Minami
  • Publication number: 20200338141
    Abstract: It is an aspect to provide a novel composition for lowering blood uric acid levels and a novel composition for preventing or ameliorating hyperuricemia. A composition for lowering blood uric acid levels comprising Bifidobacterium breve as an active ingredient is provided. A composition for preventing or ameliorating hyperuricemia comprising Bifidobacterium breve as an active ingredient is provided. A composition for lowering blood uric acid levels and a composition for preventing or ameliorating hyperuricemia can be used in a pharmaceutical composition or a food or beverage composition.
    Type: Application
    Filed: April 25, 2019
    Publication date: October 29, 2020
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Mai Murata, Junichi Minami
  • Publication number: 20200261516
    Abstract: A main object of the present technology is to provide a composition for muscle mass increase capable of effectively increasing muscle mass with fewer side effects and high safety.
    Type: Application
    Filed: October 31, 2017
    Publication date: August 20, 2020
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Kazuya Toda, Junichi Minami, Yutaka Matsunaga
  • Publication number: 20200181654
    Abstract: A technique is provided for degrading a resveratrol glycoside, or degrading a resveratrol glycoside and an isoflavone glycoside, to promote the production of an aglycone(s), thereby enhancing the absorption thereof into a living body. A bacterium belonging to the genus Bifidobacterium is used as an active ingredient of an aglycone production promoter which is used for promoting the production of an aglycone(s) from a glycoside(s). The aglycone production promoter is incorporated into a pharmaceutical composition for preventing and/or treating a disease for which an aglycone(s) is/are effective, or into a food or beverage composition for producing an aglycone(s).
    Type: Application
    Filed: June 19, 2017
    Publication date: June 11, 2020
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Ruiqing Yao, Kanetada Shimizu, Toshitaka Odamaki
  • Patent number: 10653730
    Abstract: A method for prophylaxis or treatment of a disease includes administering an an effective amount of an agent that contains cells of Lactobacillus paracasei MCC1849 (NITE BP-01633) to a subject in need of such prophylaxis or treatment. The disease can be one or more of an inflammatory disease, ulcer, food allergies, bronchial asthma, urticaria, pollinosis, anaphylactic shock or an opportunistic infection.
    Type: Grant
    Filed: August 20, 2018
    Date of Patent: May 19, 2020
    Assignee: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Tomohiro Tanaka, Noriyuki Iwabuchi, Yohei Sato, Kanetada Shimizu, Toshitaka Odamaki
  • Publication number: 20200113854
    Abstract: A composition for improving brain function contains acetic acid and/or an acetic acid salt as an active ingredient. Further suitably, the brain function improvement is brain dysfunction improvement or cognitive dysfunction improvement. Further suitably, the cognitive dysfunction is Alzheimer's-type dementia or vascular dementia. Further suitably, the composition is for oral intake. Further suitably, the composition is a food or drink composition for improving brain function.
    Type: Application
    Filed: May 17, 2018
    Publication date: April 16, 2020
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Youdai Kobayashi, Tetsuya Kuhara
  • Publication number: 20200038460
    Abstract: An object of the present invention is to provide an agent for improving a mental health disfunction or a composition for improving a mental health disfunction, and a food or drink composition for improving a mental health disfunction which are effective for improving a mental health disfunction, which are highly safe, and which can be continuously ingested on a daily basis, and this object is achieved by an agent for improving a mental health disfunction or a composition for improving a mental health disfunction, or a food or drink composition for improving a mental health disfunction, each comprising as an active ingredient a bacterium belonging to Bifidobacterium longum subsp. infantis.
    Type: Application
    Filed: February 22, 2018
    Publication date: February 6, 2020
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Hirosuke Sugahara, Kanetada Shimizu, Toshitaka Odamaki, Yeong Yeh Lee
  • Publication number: 20190381128
    Abstract: The present invention addresses the problem of providing an exceptional GLP-1 secretagogue that is a component derived from milk, a composition for promoting GLP-1 secretion, and a food/beverage or drug containing the same. Any selected from the group consisting of micellar casein, a hydrolysate thereof, a fraction thereof, a purified product thereof, and peptides including an amino acid sequence indicated by any of SEQ ID NOS.: 1-7 is configured as an active ingredient of a GLP-1 secretagogue and a composition for promoting GLP-1 secretion.
    Type: Application
    Filed: February 26, 2018
    Publication date: December 19, 2019
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Tohru Hira, Hiroshi Hara, Yosuke Komatsu, Hirohisa Izumi
  • Publication number: 20190297909
    Abstract: Provided is a composition for preventing or ameliorating a functional gastrointestinal disorder whose active ingredient is Bifidobacterium breve MCC1274 (FERM BP-11175). A composition for preventing or ameliorating a functional gastrointestinal disorder in the present technology can prevent or improve constipation or frequent bowel movements, regulate the number of bowel movements, improve stool quality, prevent or improve constipation, prevent or ameliorate bloating, or prevent or improve abdominal discomfort. Disclosed is a composition for preventing or ameliorating a functional gastrointestinal disorder accompanied by anxiety disorder. A composition for preventing or ameliorating a functional gastrointestinal disorder in the present technology can be used in a pharmaceutical composition or in a food or beverage composition.
    Type: Application
    Filed: March 12, 2019
    Publication date: October 3, 2019
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Mai Murata, Junichi Minami, Hazuki Maehata
  • Publication number: 20190298783
    Abstract: A composition for relieving stress comprising a Bifidobacterium breve MCC 1274 (FERMBP-11175) as an active ingredient is provided. The composition for relieving stress according to the present technology can improve or prevent stress-induced anger, confusion, tension, or fatigue, or can improve vigor., stress can be assessed by POMS or POMS 2. The composition for relieving stress according to the present technology can be used for pharmaceutical compositions and food and drink compositions.
    Type: Application
    Filed: March 12, 2019
    Publication date: October 3, 2019
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Mai Murata, Junichi Minami, Hazuki Maehata
  • Publication number: 20190297922
    Abstract: A microwave-heating system irradiates sealed packaged foods with microwaves to heat the packaged foods at 100° C. or higher for heat sterilization. The microwave-heating system includes a microwave generator to irradiate the packaged foods with microwaves of 2450 MHz in a multi-mode and a microwave generator to irradiate the packaged foods in a waveguide with microwaves of 915 MHz in a single-mode.
    Type: Application
    Filed: March 12, 2019
    Publication date: October 3, 2019
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Yasuhiro Takeda, Atsushi Furuya, Takahiro Koyama, Hiroyuki Ikeda, Junichi Otsuji, Shuji Obi, Yasuji Yamamoto, Junichi Kodama
  • Patent number: 10398162
    Abstract: A major object of the present technology is to provide a technology for obtaining an aloe extract which has an excellent processability into foods and contains sufficient amounts of ?-sitosterol and aloe-derived dietary fibers as functional components. The present technology provides a method for manufacturing an aloe extract containing ?-sitosterol, phospholipids, and dietary fibers which involves carrying out: a homogenization step for homogenizing an aloe mesophyll solution; an enzymatic degradation step for adding a polysaccharide-degrading enzyme to the homogenized aloe mesophyll solution and degrading polysaccharides contained in the aforementioned homogenized aloe mesophyll solution; and a membrane filtration step for membrane-filtering the enzyme-degraded aloe mesophyll solution with a microfiltration membrane or an ultrafiltration membrane and recovering the retentate fraction as an aloe extract.
    Type: Grant
    Filed: March 19, 2015
    Date of Patent: September 3, 2019
    Assignee: MORINAGA MILK INDUSTRY CO., LTD.
    Inventor: Naoki Yuda
  • Patent number: 10329604
    Abstract: A kit for detecting live cells of a microorganism in a test sample by distinguishing the live cells from dead cells or injured cells by a nucleic acid amplification method includes the following components: 1) an agent capable of covalently binding to DNA or RNA of the microorganism by irradiation with light having a wavelength of 350 nm to 700 nm; 2) an agent for suppressing a nucleic acid amplification inhibitory substance; and 3) a primer or primers for amplifying a target region of the DNA or RNA of the microorganism to be detected by a nucleic acid amplification method. The agent for suppressing a nucleic acid amplification inhibitory substance is one or more selected from albumin, dextran, T4 gene 32 protein, acetamide, betaine, dimethyl sulfoxide, formamide, glycerol, polyethylene glycol, soybean trypsin inhibitor, ?2-macroglobulin, tetramethylammonium chloride, lysozyme, phosphorylase and lactate dehydrogenase.
    Type: Grant
    Filed: June 21, 2016
    Date of Patent: June 25, 2019
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Takashi Soejima, Frank Schlitt-Dittrich
  • Publication number: 20190083549
    Abstract: A novel agent useful for improving brain function is provided. The active ingredient in this agent is a Bifidobacterium breve and/or a Bifidobacterium breve-containing cultured material is provided.
    Type: Application
    Filed: November 28, 2018
    Publication date: March 21, 2019
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Yodai Kobayashi, Tetsuya Kuhara, Kanetada Shimizu, Takumi Sato
  • Publication number: 20180369298
    Abstract: To provide a technology capable of promoting growth of Bifidobacterium bacteria and lactic acid bacteria under an environment causing the growth or no change in cell count while suppressing decrease under an environment causing the decrease. Provided is an agent for promoting the growth of, and/or suppressing a decrease in, Bifidobacterium bacteria and/or lactic acid bacteria containing Arthrospira blue-green algae and/or Spirulina blue-green algae as an active ingredient. Also provided is an oral composition including Arthrospira blue-green algae and/or Spirulina blue-green algae together with at least one type of bacteria selected from the group consisting of Bifidobacterium bacteria and lactic acid bacteria.
    Type: Application
    Filed: December 19, 2016
    Publication date: December 27, 2018
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Kengo FUJII, Hirofumi MIYAUCHI, Yohei SATO
  • Publication number: 20180280483
    Abstract: An agent for protecting upper respiratory tracts or a food or drink composition for protecting upper respiratory tracts which is effective in ameliorating various symptoms relating to upper respiratory tracts is provided. An agent for protecting upper respiratory tracts and a food or drink composition for protecting upper respiratory tracts containing lactoferrin, lactoperoxidase, glucose oxidase, glucose source, and a pH adjusting component as active ingredients is provided. The agent for protecting an upper respiratory tract according to the present invention and the food or drink composition for protecting an upper respiratory tract can ameliorate various symptoms relating to upper respiratory tracts.
    Type: Application
    Filed: July 15, 2016
    Publication date: October 4, 2018
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Kouichirou SHIN, Hiroyuki WAKABAYASHI, Masahiko KUROKAWA
  • Patent number: 10080377
    Abstract: The present disclosure provides a method for manufacturing an excellent denatured whey protein having no adverse effect on the characteristics of a product. A method for manufacturing a denatured whey protein comprising processing a whey protein solution by repeating the following steps (1) and (2) 2 times or more continuously: (1) a step for treating the whey protein solution on pressure at 50 MPa or higher and on heating at 85 to 100° C.; and, (2) a step for decompressing to 0.05 to 0.5 MPa after the treating of the aforementioned step (1) and maintaining the temperature within the range of the heating temperature of the aforementioned step (1) ±10° C.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: September 25, 2018
    Assignee: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Hiroshi Arase, Manabu Suzuki
  • Patent number: 10064903
    Abstract: The Lactobacillus paracasei MCC1849 (NITE BP-01633) strain, which has a high IL-12 production-promoting action, is used as an ingredient of a drug, food or drink, or feed used for promotion of IL-12 production, immunostimulation, antivirus, or the like.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: September 4, 2018
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Tomohiro Tanaka, Noriyuki Iwabuchi, Yohei Sato, Kanetada Shimizu, Toshitaka Odamaki
  • Patent number: 9944543
    Abstract: A power control device supplies electrolysis voltage and electrolysis current, based on input direct-current power, to an electrolytic cell for manufacturing electrolysis water by electrolysis on a raw material solution by means of electric current applied between an anode and a cathode.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: April 17, 2018
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Koki Matsuyama, Shigehiro Kobayashi
  • Patent number: 9903029
    Abstract: The invention is a bipolar-electrode electrolytic cell (1) which includes a chassis (2), an electrode plate (3) and a plate-shape spacer (4) having a concavity (25) disposing the electrode plate (3), wherein an unit cell (C), which is formed by connecting a plurality of spacers (4) in which the electrode plate (3) is disposed on the concavity (25) so that one plate surface of the electrode plate (3) is directed to one direction, is disposed inside the chassis (2). The bipolar-electrode electrolytic cell (1) includes engaged portions (35, 50 and 51) which are provided on any one of the concavity (25) of the spacer (4) or the electrode plate (3) and engaging portions (10A and 10B) which are formed the other portion with respect to the one portion.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: February 27, 2018
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Koki Matsuyama, Yamato Matsuzaki